The US Erectile Dysfunction Drugs Market is witnessing unprecedented transformation, characterized by substantial growth and innovation. The market is anticipated to reach USD 2.5 billion by 2035, with rising demand supported by a CAGR of 4.43%. The evolution within this sector is largely driven by changing societal attitudes toward sexual health issues, paving the way for more open discussions...